STAMFORD, CT – June 12, 2007 -- ArisGlobal, the leading provider of
pharmacovigilance and safety systems to the life science industry, today
announced its strategic partnership with Johnson & Johnson (NYSE: JNJ). Johnson
& Johnson will deploy the ArisGlobal Total Safety suite of products on a global
basis to replace its in-house systems.
Johnson & Johnson’s goal was to select a partner who could supply a single,
harmonized platform to provide global, state of the art safety case management,
signal detection and surveillance capabilities. In addition, Johnson & Johnson
needed a partner with a shared vision and strategy to evolve and develop systems
to meet the current and future demands of a global organization such as Johnson
& Johnson.
Johnson & Johnson selected ArisGlobal as its partner because ArisGlobal provides
the most comprehensive safety solutions on the market today, but more
importantly, shares Johnson & Johnson’s vision and strategy on the future of
drug safety.
“We chose ArisGlobal because they understand our business environment and
demonstrated excellent commitment during our business and technology
requirements sessions. The services and functionality provided with ARISg
combined with our development partnership with ArisGlobal to enhance ARISg will
support our requirements,” said William Truhe, Vice President of Informatics,
Benefit Risk Management at Johnson & Johnson Pharmaceutical Research &
Development, L.L.C. “With ArisGlobal’s ARISg robust feature set, flexible data
model ,intuitive user interface and ability to integrate with our key systems,
Johnson & Johnson will incorporate this solution into our existing
enterprise-wide processes, knowing that they have the ability to perform
enhancements at an efficient pace.”.
"The fact that Johnson & Johnson has entrusted ArisGlobal to support their most
critical business needs is extremely satisfying. It is widely known that Johnson
& Johnson has been at the forefront of drug safety initiatives and our
partnership with them will allow us to develop a solid pharmacovigilance and
risk management platform to satisfy the demands of government, the regulators
and the consumer," said Simon Sparkes, Vice President, Global Sales and
Marketing at ArisGlobal.
About ArisGlobal, L.L.C.
ArisGlobal, L.L.C. is a leading provider of Pharmacovigilance and Safety,
Registration Information Management, Clinical Trials Management and Medical
Communications software solutions to the Life Sciences industry. ArisGlobal’s
software solutions are being used by over 130 life science companies around the
world. ArisGlobal software helps companies meet international regulatory
requirements, manage risk, improve operational efficiencies and easily share
mission-critical information on a global basis.
About Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., is part of
Johnson & Johnson, the world's most broadly based producer of health care
products. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., is
headquartered in Raritan, New Jersey (USA), and has facilities throughout Europe
and the United States. Johnson & Johnson Pharmaceutical Research & Development,
L.L.C., is leveraging drug discovery and drug development in a variety of
therapeutic areas to address unmet medical needs worldwide.
MEDIA CONTACT:
Dawn Williams
Corporate Marketing
ArisGlobal
Phone: +44 (0)1908 506075
E-mail: dwilliams@arisglobal.com
http://www.arisglobal.com/
